Physostigmine as a treatment for gamma-hydroxybutyrate toxicity: A review

Journal of Toxicology - Clinical Toxicology

Volumn 40, Issue 6, 2002, Pages 781-787

  Traub, Stephen J ^a   Nelson, Lewis S ^a   Hoffman, Robert S ^a  

^a NEW YORK CITY POISON CONTROL CENTER   (United States)

Author keywords

Gamma hydroxybutyrate; Physostigmine; Treatment

Indexed keywords

4 HYDROXYBUTYRIC ACID; FLUMAZENIL; NALOXONE; PHYSOSTIGMINE;

ANESTHESIA; AROUSAL; DATA BASE; DISEASE COURSE; DRUG EFFECT; EMERGENCY WARD; HUMAN; MEDICAL LITERATURE; MEDLINE; PREMEDICATION; REVIEW; SEDATION; TOXICITY; UNCONSCIOUSNESS;

CHOLINESTERASE INHIBITORS; EMERGENCY MEDICAL SERVICES; HUMANS; HYPNOTICS AND SEDATIVES; PHYSOSTIGMINE; POISONING; SODIUM OXYBATE;

ANIMALIA;

EID: 0036445227     PISSN: 07313810     EISSN: None     Source Type: Journal    
DOI: 10.1081/CLT-120015839     Document Type: Review

References (48)

1. Schwartz, R.H.; Milteer, R.; LeBeau, M.A. Drug-facilitated sexual assault ("Date Rape"). South. Med. J. 2000, 93, 558-561.
2. Drug Abuse Warning Network. The DAWN Report: Club Drugs - December 2000. www.samhsa.gov/oas/dawn/ clubdrug.htm (accessed May 10, 2002).
3. Chin, R.L.; Sporer, K.A.; Cullison, B.; Dyer, J.E.; Wu, T.D. Clinical course of γ-hydroxybutyrate overdose. Ann. Emerg. Med. 1998, 31 (6), 716-722.
4. Li, J.; Stokes, S.A.; Woeckener, A. A tale of novel intoxication: A review of the effects of γ-hydroxybutyric acid with recommendations for management. Ann. Emerg. Med. 1998, 31 (6), 729-736.
5. Okun, M.S.; Boothby, L.A.; Bartfield, R.B.; Doering, P.L. GHB: An important pharmacologic and clinical update. J. Pharm. Sci. 2001, 4 (6), 167-175.
6. Vayer, P. Minireview: Gamma-Hydroxybutyrate, a possible neurotransmitter. Life Sci. 1987, 41, 1547-1557.
7. Cash, C.D. Gammahydroxybutyrate: An overview of the pros and cons for it being a neurotransmitter and/or a useful therapeutic agent. Neurosci. Biobehav. Rev. 1994, 18 (2), 291-304.
8. Tunnicliff, G. Sites of action of gamma-hydroxybutyrate (GHB) - A neuroactive drug with abuse potential. J. Toxicol. Clin. Toxicol. 1997, 35 (6), 581-590.
9. Snead, O.C. Evidence for a G protein-coupled Gamma-Hydroxybutyric acid receptor. J. Neurochem. 2000, 75 (5), 1986-1996.
10. Howland, M.A. Antidotes in depth: Physostigmine. In Goldfrank's Toxicologic Emergencies, 6th Ed.; Goldfrank, L.R., Flomenbaum, N.E., Lewin, N.A., Weisman, R.S., Howland, M.A., Hoffman, R.S., Eds.; Appleton & Lange: Stamford, CT, 1998; 614-617.
11. Havasi, G.; Havasi, I.; Gintautas, J.; Kraynack, B.J. Is physostigmine a pure analeptic agent? A clinical evaluation. Proc. West. Pharmacol. Soc. 1982, 25, 35-37.
12. Nattel, S.; Bayne, L.; Ruedy, J. Physostigmine in coma due to drug overdose. Clin. Pharmacol. Ther. 1979, 25 (1), 97-102.
13. Nilsson, E. Physostigmine treatment in various drug-induced intoxications. Ann. Clin. Res. 1982, 14, 165-172.
14. Rupreht, J.; Dworacek, B. Physostimine versus naloxone in heroin-overdose. J. Toxicol. Clin. Toxicol. 1983-84, 21 (3), 387-397.
15. Livingston, A.; Waterman, A. The effects of cholinergic and anticholinergic drug on ketamine anaesthesia in rats [Proceedings]. J. Physiol. 1978, 277, 56P.
16. Foote, G.; Livingston, A. A comparison of the effects of physostigmine and atropine on ketamine, althesin and pentobarbitone in rats [Proceedings]. J. Physiol. 1978, 284, 132P-133P.
17. Di Liberti, J.; O'Brien, M.L.; Turner, T. The use of physostigmine as an antidote in accidental diazepam intoxication. J. Pediatr. 1975, 86, 106-107.
18. Yates, S.W.; Viera, A.S. Physostigmine in the treatment of gamma-hydroxybutyric acid overdose. Mayo Clin. Proc. 2000, 75, 401-402.
19. Caldicott, D.G.; Kuhn, M. Gamma-hydroxybutyrate overdose and physostigmine: Teaching new tricks to an old drug? Ann. Emerg. Med. 2001, 37, 99-102.
20. Henderson, R.S.; Holmes, C.M. Reversal of the anaesthetic action of sodium gamma-hydroxybutyrate. Anesthesiol. Intensive Care 1976, 4, 351-354.
21. Holmes, C.M.; Henderson, R.S. The elimination of pollution by a non-inhalational technique. Anaesthesiol. Intensive Care 1978, 6, 120-124.
22. Mullins, M.E.; Dribben, W. The use of physostigmine in the management of gamma-hydroxybutyrate overdose. Ann. Emerg. Med. 2001, 38, 347-348.
23. Boyer, E.W.; Quang, L.; Woolf, A.; Shannon, M. Use of physostigmine in the management of gamma-hydroxybutyrate overdose. Ann. Emerg. Med. 2001, 38 (3), 346-347.
24. Holmes, C.M. "Fantasy" - Drug of abuse. N. Z. Med. J. 2000, 114 (1107), 129.
25. Dean, W. Physostigmine treatment of γ-hydroxybutyric acid overdose: Appropriate or inappropriate use of a reversal agent? (Letter). Mayo Clin. Proc. 2000, 75, 872.
26. Mullins, M.E.; Dribben, W. Physostigmine treatment of γ-hydroxybutyric acid overdose: Appropriate or inappropriate use of a reversal agent? (Letter). Mayo Clin. Proc. 2000, 75, 871-872.
27. Nelson, L.S.; Howland, M.A.; Hoffman, R.S. Central nervous system depression after ingestion of renewtrient (Letter). N. Engl. J. Med. 1999, 343, 570.
28. Viera, A.J.; Yates, S.W. Toxic ingestion of gamma- hydroxybutyric acid. South. Med. J. 1999, 92 (4), 404-405.
29. Ward, D. Physostigmine treatment of γ-hydroxybutyric acid overdose: Appropriate or inappropriate use of a reversal agent? (Letter). Mayo Clin. Proc. 2000, 75, 870-871.
30. Olson, K.R.; Dyer, J.E.; Haller, C. Central nervous system depression after ingestion of renewtrient (Letter). N. Engl. J. Med. 1999, 343, 570.
31. Gorton, C. Butyrolactone-induced central nervous system depression after ingestion of renewtrient, a "Dietary Supplement" (Letter). N. Engl. J. Med. 1989, 339, 848.
32. Yates, S. Physostigmine treatment of γ-hydroxybutyric acid overdose: Appropriate or inappropriate use of a reversal agent? (Letter). Mayo Clin. Proc. 2000, 75, 872-873.
33. Kuhn, M.; Caldicott, K. Use of physostigmine in the management of gamma-hydroxybutyrate overdose. Ann. Emerg. Med. 2001, 38 (3), 347-348.
34. Kleinschmidt, S.; Schellhase, C.; Mertzlufft, F. Continuous sedation during spinal anesthesia: Gamma-hydroxybutyrate vs. propofol. Eur. J. Anesthesiol. 1999, 16, 23-30.
35. Larson, G.F.; Hulbert, B.J.; Wingard, D.W. Physostigmine reversal of diazepam-induced depression. Anesth. Analg. 1977, 56, 348-351.
36. Bidwai, A.V.; Stanley, T.H.; Gogers, C.; Riet, E.K. Reversal of diazepam-induced postanesthetic somnolence with physostigmine. Anesthesiology 1979, 51, 256-259.
37. Nagy, J.L.; Decsi, L. Physostigmine, a highly potent antidote for acute experimental diazepam intoxication. Neuropharmacology 1978, 17, 469-475.
38. Avant, G.R.; Speeg, K.V.; Freemon, F.R.; Schenker, S.; Bermak, M.L. Physostigmine reversal of diazepam-induced hypnosis: A study in human volunteers. Ann. Intern. Med. 1979, 91, 53-55.
39. Wax, P.M. Analeptic use in clinical toxicology: A historical appraisal. J. Toxicol. Clin. Toxicol. 1997, 35 (2), 203-209.
40. Clemmesen, C.; Nilsson, E. Therapeutic trends in the treatment of barbiturate poisoning (The Scandinavian Method). Clin. Pharmacol. Ther. 1961, 2 (2), 220-229.
41. Sethy, V.H.; Roth, R.H.; Walters, J.R.; Marini, J.; Van Woert, M.H. Effect of Anesthetic Doses of γ-Hydroxybutyrate on the Acetylcholine Content of Rat Brain. Naunyn-Schmiedebergs Arch. Pharmacol. 1976, 295, 9-14.
42. Ladinsky, H.; Consolo, S.; Zatta, A.; Vezzani, A. Mode of action of gamma-butyrolactone on the central cholinergic system. Naunyn-Schmiedebergs Arch. Pharmacol. 1983, 322, 42-48.
43. Giaraman, N.J.; Schmidt, K.F. Some neurochemical aspects of the depressant action of γ-butyrolactone on the central nervous system. Br. J. Pharmacol. 1963, 20, 563-568.
44. Muller-Schwefe, G.; Penn, R.D. Physostigmine in the treatment of intrathecal baclofen overdose. J. Neurosurg. 1989, 71, 273-275.
45. Saltuari, L.; Baumgartner, H.; Kofler, M.; Schmutzhard, E.; Russegger, L.; Aichner, F.; Gerstenbrand, F. Failure of Physostigmine in the treatment of acute severe intrathecal baclofen intoxication. N. Engl. J. Med. 1990, 322, 1533-1534.
46. Delhaas, E.M.; Brouwers, J.R. Intrathecal baclofen overdose: Report of 7 events in 5 patients and review of the literature. Int. J. Clin. Pharmacol. Ther. Toxicol. 1991, 29, 274-280.
47. Rushman, S.; McLaren, I. Management of intrathecal baclofen overdose. Intensive Care Med. 1999, 25 (2), 239.
48. Kirk, M.A. Anticholinergics and antihistamines. In Clinical Management of Poisoning and Drug Overdose, 3rd Ed.; Haddad, L.M., Shannon, M.W., Winchester, J.F., Eds.; W.B. Saunders Co.: Philadelphia, 1998; 641-649.